Sherifa Ahmed Hamed Selected Research

Sherifa Ahmed Hamed Research Topics

Disease

7	Epilepsy (Aura) 11/2020 - 05/2008
4	Seizures (Absence Seizure) 11/2020 - 05/2008
2	Temporal Lobe Epilepsy 11/2020 - 11/2019
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Virilism (Virilization) 03/2021
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2021
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 11/2019
1	Psychotic Disorders (Schizoaffective Disorder) 11/2019
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 11/2018
1	Tension-Type Headache (Tension Headache) 07/2018
1	Erectile Dysfunction 07/2018
1	Partial Epilepsies (Epilepsy, Partial) 07/2018
1	Facial Pain (Myofacial Pain) 07/2018
1	Fibromyalgia (Fibrositis) 07/2018
1	Sciatica (Sciatic Neuralgia) 07/2018
1	Migraine Disorders (Migraine) 07/2018
1	Neuralgia (Stump Neuralgia) 07/2018
1	Anxiety Disorders (Anxiety Disorder) 07/2018
1	Orthostatic Hypotension (Postural Hypotension) 06/2018
1	Tachycardia (Tachyarrhythmias) 06/2018
1	Diabetes Complications 06/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2017
1	Fanconi Syndrome (Syndrome, Fanconi) 09/2017
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 09/2017
1	Fibrosis (Cirrhosis) 09/2017
1	Inflammation (Inflammations) 09/2017
1	Urolithiasis 09/2017
1	Hypothyroidism 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Infections 03/2008
1	Brain Ischemia (Cerebral Ischemia) 03/2008
1	Diabetic Angiopathies (Diabetic Angiopathy) 03/2008
1	Atherosclerosis 03/2008
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2006

Drug/Important Bio-Agent (IBA)

7	Anticonvulsants (Antiepileptic Drugs)IBA 11/2020 - 05/2008
4	Carbamazepine (Tegretol)FDA LinkGeneric 11/2020 - 01/2015
4	Valproic Acid (Depakote)FDA LinkGeneric 11/2020 - 01/2015
2	Levetiracetam (Keppra)FDA LinkGeneric 11/2020 - 11/2019
2	Testosterone (Sustanon)FDA Link 01/2020 - 05/2008
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2020 - 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	SteroidsIBA 03/2021
1	SaltsIBA 03/2021
1	AndrogensIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 11/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2018
1	Pregabalin (Lyrica)FDA Link 07/2018
1	Prostaglandins BIBA 07/2018
1	gamma-Aminobutyric Acid (GABA)IBA 07/2018
1	hydroxide ionIBA 06/2018
1	Topiramate (Topamax)FDA LinkGeneric 12/2017
1	Pharmaceutical PreparationsIBA 12/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 09/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 09/2017
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 09/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 09/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2015
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2015
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2015
1	Tiagabine (Gabitril)FDA Link 01/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	GlobulinsIBA 01/2015
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2015
1	ProlactinIBA 05/2008
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 05/2008
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2008
1	Hormones (Hormone)IBA 05/2008
1	Follicle Stimulating Hormone (Follitropin)FDA Link 05/2008
1	Estrogens (Estrogen)FDA Link 05/2008
1	Dehydroepiandrosterone (DHEA)IBA 05/2008
1	Interleukin-6 (Interleukin 6)IBA 03/2008
1	Triglycerides (Triacylglycerol)IBA 03/2008
1	Biomarkers (Surrogate Marker)IBA 03/2008
1	Blood Glucose (Blood Sugar)IBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008
1	DystrophinIBA 01/2006

Therapy/Procedure

4	Therapeutics 03/2021 - 09/2017
2	Transcranial Magnetic Stimulation 11/2020 - 01/2020
1	Off-Label Use 07/2018
1	Glycemic Control 06/2018